Component-resolved-diagnosis and validation of an allergen-microarray technology. Romy Gadisseur 1, Jean-Paul Chapelle 1, Etienne Cavalier 1 1 : University.

Slides:



Advertisements
Similar presentations
Egg Allergy Important food allergy in children Starts early in life
Advertisements

1 Literature Review Peter R. McNally, DO, FACP, FACG University Colorado at Denver School of Medicine Center for Human Simulation Aurora, Colorado
f416 rTri a 19; Omega-5 Gliadin - a risk marker for severe immediate or exercise-induced reactions in patients with suspected wheat allergy.
Peanut Allergy 10% of children are sensitized but only 1-2% have symptoms Usually life-long Symptoms range from local reactions to anaphylaxis Very small.
ImmunoCAP ISAC Customer days
Bischenberg, 23 rd September 2007The GA 2 LEN/EAACI Allergy School Effects of heat treatment and proteolytic enzymes on allergenicity Dr. Montserrat Fernández.
Pet Allergen Diagnosis Protein Array Excelsior Bio-system Kang Hsin Chen Excelsior Bio-system Kang Hsin Chen.
Literature support Test chart for the use of ImmunoCAP ® Allergen components Suspicion of fruit allergy Risk for severe reactions?
A. Nakonechna 1, J. Antipkin 2, T. Umanets 2, V. Lapshyn 2 1) Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom.
Immunopathological reaction (reaction of hypersensitivity) type I.
Recombinant Weed Allergens Nicole Wopfner Christian Doppler Laboratory for Allergy Diagnosis and Therapy Department of Molecular Biology University of.
Soy Allergy Important protein source Sensitization frequency varies largely Prevalence of soy allergy % Symptoms –cuteaneous or gastrointestinal.
Literature support Test chart for the use of ImmunoCAP® Allergen components Suspicion of peanut allergy Risk for severe reactions?
J. Antipkin 1, T. Umanets 1, V. Lapshyn 1, A. Nakonechna 2 1) Institute of Pediatry, Obstetrics and Gynaecology, Kiev, Ukraine 2) Royal Liverpool and Broadgreen.
1 Microarrays for allergy - ImmunoCAP ISAC © - Phn Romy GADISSEUR, Prof. J-P. Chapelle, Phn. Biol. E. Cavalier 02/03/2009.
1 Change of Potency Assay for Standardized Short Ragweed Pollen and Cat Allergen Extracts Ronald L. Rabin, MD Chief, Laboratory of Immunobiochemistry CBER/OVRR/DBPAP.
Allergen regulation in the future : what will be the place for recombinant allergens ? Jacqueline DAYAN-KENIGSBERG European Academy of Allergology and.
New technologies in allergology Workshop Ph.Biol. Romy GADISSEUR 16/10/2010.
San Diego, February 2010 – AAAS Annual Meeting 1 Food Allergies: The Enemy Within Krzysztof Maruszewski European Commission Joint Research Centre.
Svetlana Sergejeva, MD, PhD Estonian Biotechnology Programme.
Allergenicity assessment of genetically modified organisms (GMOs )
Microarrays for allergy
Laboratory of Immunobiochemistry site visit Jay E. Slater, MD FDA/CBER/OVRR/DBPAP June 29, 2006.
Dau c 1.02/Ubiquitin C C A C A C A C A Hours post infection Dau c 1.01/Ubiquitin A B Figure S 1 A and.
Animal derived allergenic molecules Christiane Hilger Laboratory of Immunogenetics and Allergology CRP-Santé Luxembourg.
ISAC and Component-resolved Diagnosis
Latex Allergy Loma Linda University Medical Center Murrieta Food and Nutrition Services Presented by Cindi Rafoth, RD Created by Gena Alltizer.
Historical overview Pr G. Pauli Hôpitaux Universitaires de Strasbourg Bischenberg 21 septembre 2007.
The prevalence of allergic diseases and the overall pattern of sensitization among years old adolescents in two Danish birth cohorts 14 years apart.
4.02R Foods I “MOST WANTED” 4.02RFoods I Most Wanted.
Allergens Department of Allergology, Clinical Immunology and Internal Diseases Collegium Medicum in Bydgoszcz Ewa Gawronska - Ukleja Ewa Gawronska - Ukleja.
Hypersensitivity Type III and IV. Classification of Hypersensitivity TypeMechanismExample I IgE mediatedSystemic anaphylaxis eg peanut allergy Asthma.
Daniel B. Jamieson, Elizabeth C. Matsui, Andrew Belli1, Meredith C. McCormack, Eric Peng Simon Pierre-Louis, Jean Curtin-Brosnan, Patrick N. Breysse, Gregory.
AdvanSure ® for diagnosis of specific IgE Park, Jung-Won Allergy-Asthma Clinic, Severance Hospital.
ALERBLOT: Interest of 2D Immunoblot in diagnosis of wheat allergy
Suggested IgE ab testing of suspected soy allergic patients
Sensitization profile in a group of Spanish patients allergic to LTP
Natural latex, grass pollen, and weed pollen share IgE epitopes
Changes in allergy manifestations, sensitization and
MOSCOW INFANTS: ATOPIC DERMATITIS,
62 Patients with positive sIgE f13 or n n= 38 (f13), n=24 (f17)
Allergy diagnosis for inhalant immunotherapy
Laboratory Diagnosis of Human Allergic Disease R.G. Hamilton, Ph.D. D.ABMLI Professor of Medicine and Pathology Johns Hopkins University School of Medicine.
Identification of common allergenic structures in mugwort and ragweed pollen  Reinhold Hirschwehr, MDa, Claudia Heppner, MSca, Susanne Spitzauer, MDb,
Margaretha A. Faber, MD, PhD, Athina L. Van Gasse, MD, Ine I
Angel Vallverdú, BSc, Juan A. Asturias, PhD, M
Natural latex, grass pollen, and weed pollen share IgE epitopes
Plantago lanceolata: An important trigger of summer pollinosis with limited IgE cross- reactivity  Gabriele Gadermaier, PhD, Stephanie Eichhorn, MSc, Eva.
Sabine Fischer, MSc,a, Monika Grote, PhD,b, B. Fahlbusch, PhD,c, W. D
Allergen-specific IgE production of committed B cells from allergic patients in vitro  Peter Steinberger, MSca, Barbara Bohlea, Franco di Padova, MDb,
Firdaus Hamid, MD, PhD, Serge A. Versteeg, BSc, Aprilianto E
No evidence of intrauterine sensitization against inhalant allergens
Heimo Breiteneder, PhD, Christof Ebner, MD 
Prevalence of allergic sensitization in the United States: Results from the National Health and Nutrition Examination Survey (NHANES)   Päivi.
Component-resolved diagnosis of baker's allergy based on specific IgE to recombinant wheat flour proteins∗  Ingrid Sander, PhD, Hans-Peter Rihs, PhD,
Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults  Christian Lupinek, MD,
Intrauterine sensitization of allergen-specific IgE analyzed by a highly sensitive new allergen microarray  Norio Kamemura, MSc, Hitomi Tada, MSc, Naoki.
Prediction of peanut allergy in adolescence by early childhood storage protein-specific IgE signatures: The BAMSE population-based birth cohort  Anna.
Component-Resolved Diagnosis (CRD) of Type I Allergy with Recombinant Grass and Tree Pollen Allergens by Skin Testing  Susanne Heiss, Rudolf Valenta 
Allergen microarray detects high prevalence of asymptomatic IgE sensitizations to tropical pollen-derived carbohydrates  Clarissa R. Cabauatan, PhD, Christian.
Comparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant–negative patients with bee venom allergy  Thilo.
Component resolution reveals additional major allergens in patients with honeybee venom allergy  Julian Köhler, MS, Simon Blank, PhD, Sabine Müller, MD,
ImmunoCAP cellulose displays cross-reactive carbohydrate determinant (CCD) epitopes and can cause false-positive test results in patients with high anti-CCD.
Component-resolved diagnosis of kiwifruit allergy with purified natural and recombinant kiwifruit allergens  Merima Bublin, PhD, Marina Pfister, MD, Christian.
Allergy caused by ingestion of zucchini (Cucurbita pepo) : Characterization of allergens and cross-reactivity to pollen and other foods  Jürgen Reindl,
Kerstin Bauermeister, MSc, Barbara K
Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for.
Reply Journal of Allergy and Clinical Immunology
Fig. 2. Scattered plots of food allergen sIgE concentrations, as measured by the ImmunoCAP® assay (x-axis) and the Allergy-Q® assay (y-axis). Each line.
Presentation transcript:

Component-resolved-diagnosis and validation of an allergen-microarray technology. Romy Gadisseur 1, Jean-Paul Chapelle 1, Etienne Cavalier 1 1 : University Hospital of Liège, Department of Clinical Chemistry, Liège, Belgium; 1. Background: In the laboratory, the diagnosis of Type I allergy is generally performed by measuring the specific IgE antibodies (sIgE) using allergen extracts. In the recent years, a large number of allergens from various sources have been characterized. Indeed, for some sources, a complex allergen expression pattern has been described. Recombinant allergens can be used for Component-Resolved- Diagnosis (CRD) of the patients’allergen sensitization profile, whereas allergen extracts allow us to identify allergen-containing sources. CRD permits to diagnose the genuine sensitization of patients towards a given allergenic source or cross-reactive molecules that point to cross-sensitization to several allergen sources. Recently, microarrays have been developed and allows the determination of sIgE against 103 recombinant or purified allergen components from many different allergen sources in a single analytical step. The aim of our study was to establish a comparison of the sIgE results for recombinant allergens provided by the microarray method with the traditional sIgE measurements (ImmunoCAP© 250, Phadia, Uppsala, Sweden). Finally, we evaluated the effects of some patients with a high total IgE rate ( Tot IgE) on the ImmunoCAP © ISAC results. 2. Method: 2.1. Patients. We selected 86 patients with an anamnesis and a clinical diagnosis of Type 1 allergy on the basis of their sIgE tests for recombinant allergens performed with the Phadia ImmunoCAP © 250. The sIgE were directed against 55 recombinant or natural purified proteins (Table 1). Secondly, we selected two patients with a high TotIgE rate (above kU/L) to evaluate the potential unspecific binding of IgE ImmunoCAP © ISAC determination. All the samples were screened for an allergen-specific IgE determination applying the allergen microarray ImmunoCAP © ISAC according to the manufacturer’s recommendations. 3. Results : In all, 555 sIgE for recombinant allergens have been performed with ImmunoCAP © 250. –Three hundred eighty four results out of the 555 were positive (>0,10 kUA/L) with the CAP method and 171 were found negative (<0,10 kUA/L). With ImmunoCAP © ISAC, 302 out of the 384 positive results with CAP © were also found positive (concordance 78,65 %). –The mean of the 82 discrepant results measured with the ImmunoCAP © was 0.67±2.06 kUA/L. –We observed that 52 out of the 82 discrepant results were below 0,35 kUA/L, the former cut-off level of ImmunoCAP © 250. With this cut-off, the concordance of the positive results was 92,19 % (Table 2). Amongst the 171 results found negative with ImmunoCAP © 250, we observed that 160 of them were also found negative with ISAC © (concordance 93,57 %). –The mean of those 11 sIgE measured with the ISAC © technique was 1.57±3.56 ISU. No unspecific binding was observed up to kU/L. The discrepancies were more frequently observed with some specific allergens (Table 1). –Among those allergens for which we often observed negative results with the ImmunoCAP © ISAC method but positive results with ImmunoCAP © 250, we found notably of rAsp f 1 (7 discrepant results out of 14 measurements), rPru p 3 (5 discrepant results out of 13 measurements), nAna c 2 (4 discrepant results out of 11 measurements), Api g 1 (4 discrepant results out of 10 measurements). 4. Conclusions: Recently, the ImmunoCAP © ISAC allergen-microarray appeared on the market to run Component-resolved-Diagnostics. Our results show that the ImmunoCAP © ISAC performs analytically well when we compare the 555 sIgE results with the results provided by the ImmunoCAP’ 250 method. Nevertheless, it is necessary to have a better sensitivity for some allergens, notably clinically relevant allergen components like rPru p 3. Allergen sourceComponent Occurrence of componant Protein Family or function Foods Peach (Prunus persica)rPru p 126PR-10 rPru p 313nsLTP Kiwi fruit (Actinidia deliciosa) rAct d 85PR-10 Peanut (Arachis hypogea)rAra h 116 Storage protein, 7S globulin rAra h 29 Storage protein, Conglutin rAra h 310 Storage protein, Glycinin rAra h 815PR-10 Brazil nut (Bertholletia excelsa) rBer e 110 Storage protein, 2S albumin Hazelnut (Corylus avelana)rCor a 110PR-10 rCor a 814nsLTP Celery (Apium graveolens)rApi g 110PR-10 Sojabean (Glycine max)rGly m 411PR-10 Wheat (Triticum aestivum) rTri a 19 Gliadin 8Gliadin Egg white (Galus domesticus) OvomucoidnGal d 11Ovomucoid Carp (Cyprinus carpio)rCyp c 112Parvalbumin Cod (Gadus callarias)rGad c 19Parvalbumin Cow (Bos domesticus) Alpha-lactalbuminnBos d 42Alpha-lactalbumin BSAnBos d 61Serum albumin CaseinnBos d 83Casein Lactoferrin nBos d lactoferrin 1Transferrin Shrimp (Penaeus aztecus)rPen a 111Tropomyosin Grass pollen Timothy grass (Phleum pratense) rPhl p 118Grass group 1 rPhl p 1111 Ole e 1-related protein rPhl p 128Profilin rPhl p 213Grass group 2 nPhl p 412 Berberine bridge enzyme rPhl p 59Grass group 5 rPhl p 612Grass group 6 rPhl p 75Ca Binding protein Occupationnal allergens Latex (Hevea brasiliensis)rHev b 15 Rubber elongation factor rHev b 32 Small rubber particle protein rHev b 69Hevein precursor rHev b 86Profilin rHev b 111Chitinase Allergen sourceComponent Occurrence of componant Protein Family or function Tree Pollen Birch (Betula verrucosa)rBet v 129PR-10 rBet v 214Profilin rBet v 411Ca Binding protein Cypress (Cupressus arizonica) nCup a 15Pectase lyase Olive (Olea europaea)nOle e 119 Common olive group 5 Weed pollen Mugwort (Artemisia vulgaris) nArt v 17Defensin nArt v 39nsLTP Saltwort (Salsola kali)nSal k 13 Pectin methylesterase Venoms Honey bee (Apis mellifera) rApi m 12Phospholipase A2 Epidermals and other poteins Cat (Felis domesticus)rFel d 118Uteroglobin nFel d 27Serum albumin Dog (Canis familiaris)rCan f 115Lipocalin rCan f 26Lipocalin nCan f 310Serum albumin Mites House dust mitenDer p 113Cysteine protease (Dermatophagoides pteronyssinus) rDer p 105Tropomyosin rDer p 212NCP2 family Microorganism Aspergillus fumigatusrAsp f 114Mitogillin family rAsp f 616MnSOD Alternaria alternatarAlt a 121 Carbohydrate Determinants Bromelin (Ananas comosus) nAna c 211CCD Table 1: Classification of the 555 sIgE measured with ImmunoCAP©250 (CAP) and ImmunoCAP© ISAC (ISAC) including their protein family and their occurrence in the study. Table 2: Comparison of the 555 sIgE results measured with ImmunoCAP © 250 (CAP) and ImmunoCAP © ISAC (ISAC) following 2 different cut-off (0.10 and 0.35 kUA/L) for the ImmunoCAP © ISAC < 0,30 ISU ISAC ≥ 0,30 ISU CAP < 0,1 kUA/L16011 CAP ≥ 0,1 kUA/L82302 CAP < 0,35 kUA/L21227 CAP ≥ 0,35 kUA/L30286